Avicenna.AI has launched CINA-iPE, a CE-Marked artificial intelligence (AI) program for analyzing chest CT scans for the presence of incidental pulmonary embolism.
The company said it will demonstrate CINA-iPE for the first time at ECR 2023 in Vienna. CINA-iPE is the first tool in CINA Incidental, the company's suite of medical imaging programs for detecting unsuspected pathologies on CT scans.
CINA Incidental sits alongside the company's existing suite, CINA ER, which includes a range of U.S. Food and Drug Administration-cleared and CE-Marked tools for neurovascular and thoraco-abdominal emergencies, the company said.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
